What do systematic reviews say?

Serious adverse events (number) · alcohol‐related disorders (others)

Serious adverse events (number) · alcohol‐related disorders (others)

Serious adverse events (number) · alcohol‐related disorders (others)

Serious adverse events (number) · participants with alcoholic hepatitis (all severity)

Serious adverse events by day 30 · hospitalised individuals with COVID‐19 (moderate to severe disease)

Serious adverse events at longest · participants with gallstone disease (cholesterol, pigment, or mixed)

Serious adverse events at maximum · patients without heart failure

Short‐term serious adverse events · people with rheumatoid arthritis

Serious adverse events maximum · patients with suspected or diagnosed myocardial infarction

Serious adverse events: infection · people with implantable ventricular assist devices

Non‐serious adverse events Maximum · neonates and children with hospital‐acquired pneumonia

Non‐serious adverse events Maximum · neonates and children with hospital‐acquired pneumonia

One or more serious adverse events · cognitively healthy people in midlife

People with serious adverse events · people with neutropenia or neutrophil dysfunction

Serious adverse events Not reported · Patients with shoulder pain

MST vs ECT ‐ serious adverse events · patients with schizophrenia

Serious adverse events (proportion) · participants with alcoholic hepatitis (all severity)

Serious adverse events (proportion) · participants with alcoholic hepatitis (all severity)

Serious adverse events (proportion) · participants with alcoholic hepatitis (all severity)

Serious adverse events (proportion) · alcohol‐related disorders (others)